Bio-Rad (BIO) Suffers due to BioPharma Softness, Stiff Competition [Yahoo! Finance]
Bio-Rad Laboratories, Inc. Class A (BIO)
Last bio-rad laboratories, inc. class a earnings: 2/13 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
bio-rad.com/en-us/corporate/investor-relations
Company Research
Source: Yahoo! Finance
Since the beginning of 2023, Bio-Rad has been witnessing softness in smaller BioPharma companies, wherein the demand for life science products has been strong historically. This directly correlates with the funding constraints that the broader pharmaceutical industry has started to experience. Management puts forth that BioPharma's softness has resulted in sluggish growth of the Life Science segment. Going by our model, we expect Bio-Rad's Life Science arm to register a decline of 1% in 2024. In the fourth quarter of 2023, negative BioPharma macro trends persisted. Bio-Rad experienced reduced demand from biopharma customers for its process chromatography resins and from both biopharma and smaller biotech customers for the Life Science research projects – products. Bio-Rad experienced weaker demand in China due to softening macroeconomic conditions. Bio-Rad Laboratories, Inc. Price Bio-Rad Laboratories, Inc. price | Bio-Rad Laboratories, Inc. Quote In recent times, Bio-Rad's m
Show less
Read more
Impact Snapshot
Event Time:
BIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIO alerts
High impacting Bio-Rad Laboratories, Inc. Class A news events
Weekly update
A roundup of the hottest topics
BIO
News
- Bio-Rad Announces Life Science Group Management ChangesBusiness Wire
- Bio-Rad Laboratories, Inc. (NYSE: BIO) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- Digital PCR and Quantitative PCR Market Report 2024 - Global Trends, Forecast and Competitive Analysis to 2030 [Yahoo! Finance]Yahoo! Finance
- Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits? [Yahoo! Finance]Yahoo! Finance
- Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024Business Wire
BIO
Earnings
- 2/15/24 - Beat
BIO
Sec Filings
- 4/26/24 - Form 8-K
- 4/17/24 - Form 3
- 4/10/24 - Form 8-K
- BIO's page on the SEC website